1. Home
  2. PAR vs RGNX Comparison

PAR vs RGNX Comparison

Compare PAR & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$19.44

Market Cap

699.1M

Sector

Miscellaneous

ML Signal

HOLD

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

HOLD

Current Price

$8.17

Market Cap

793.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
RGNX
Founded
1968
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
699.1M
793.5M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
PAR
RGNX
Price
$19.44
$8.17
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
8
Target Price
$33.20
$28.75
AVG Volume (30 Days)
891.8K
1.2M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
18.08
EPS
N/A
N/A
Revenue
$455,547,000.00
$10,393,000.00
Revenue This Year
$9.82
$51.21
Revenue Next Year
$11.27
$19.08
P/E Ratio
N/A
N/A
Revenue Growth
30.16
126.48
52 Week Low
$11.59
$5.46
52 Week High
$53.24
$16.19

Technical Indicators

Market Signals
Indicator
PAR
RGNX
Relative Strength Index (RSI) 62.81 35.03
Support Level $12.50 $7.95
Resistance Level $22.48 $11.39
Average True Range (ATR) 0.98 0.70
MACD 0.12 -0.13
Stochastic Oscillator 82.39 10.21

Price Performance

Historical Comparison
PAR
RGNX

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). Its product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: